PA8532401A1 - Derivados de imidazol [1,5-a][1,2,4]triazolo[4,3-d][1,4] benzodiazepina - Google Patents

Derivados de imidazol [1,5-a][1,2,4]triazolo[4,3-d][1,4] benzodiazepina

Info

Publication number
PA8532401A1
PA8532401A1 PA20018532401A PA8532401A PA8532401A1 PA 8532401 A1 PA8532401 A1 PA 8532401A1 PA 20018532401 A PA20018532401 A PA 20018532401A PA 8532401 A PA8532401 A PA 8532401A PA 8532401 A1 PA8532401 A1 PA 8532401A1
Authority
PA
Panama
Prior art keywords
benzodiazepina
triazolo
imidazo
ciclopropil
etil
Prior art date
Application number
PA20018532401A
Other languages
English (en)
Spanish (es)
Inventor
Raffaello Masciadri
Andrew William Thomas
Juergen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PA8532401A1 publication Critical patent/PA8532401A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PA20018532401A 2000-11-16 2001-11-15 Derivados de imidazol [1,5-a][1,2,4]triazolo[4,3-d][1,4] benzodiazepina PA8532401A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00124332 2000-11-16

Publications (1)

Publication Number Publication Date
PA8532401A1 true PA8532401A1 (es) 2002-08-26

Family

ID=8170315

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20018532401A PA8532401A1 (es) 2000-11-16 2001-11-15 Derivados de imidazol [1,5-a][1,2,4]triazolo[4,3-d][1,4] benzodiazepina

Country Status (40)

Country Link
US (1) US6743789B2 (https=)
EP (1) EP1337535B1 (https=)
JP (1) JP4088151B2 (https=)
KR (1) KR100504300B1 (https=)
CN (1) CN1191255C (https=)
AR (1) AR031345A1 (https=)
AT (1) ATE268776T1 (https=)
AU (2) AU1700702A (https=)
BG (1) BG107817A (https=)
BR (1) BR0115393A (https=)
CA (1) CA2427576C (https=)
CZ (1) CZ295256B6 (https=)
DE (1) DE60103776T2 (https=)
DK (1) DK1337535T3 (https=)
EC (1) ECSP034607A (https=)
ES (1) ES2220831T3 (https=)
GC (1) GC0000375A (https=)
GT (1) GT200100230A (https=)
HR (1) HRP20030360A2 (https=)
HU (1) HUP0303281A3 (https=)
IL (1) IL155813A0 (https=)
JO (1) JO2359B1 (https=)
MA (1) MA26962A1 (https=)
MX (1) MXPA03004251A (https=)
MY (1) MY141675A (https=)
NO (1) NO324706B1 (https=)
NZ (1) NZ525413A (https=)
PA (1) PA8532401A1 (https=)
PE (1) PE20020583A1 (https=)
PL (1) PL362925A1 (https=)
PT (1) PT1337535E (https=)
RU (1) RU2278865C2 (https=)
SI (1) SI1337535T1 (https=)
SK (1) SK7232003A3 (https=)
TR (1) TR200402073T4 (https=)
TW (1) TWI239333B (https=)
UY (1) UY27026A1 (https=)
WO (1) WO2002040487A2 (https=)
YU (1) YU35603A (https=)
ZA (1) ZA200303435B (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686352B2 (en) 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
JP4616770B2 (ja) * 2003-06-19 2011-01-19 第一三共株式会社 選択的なアミノ置換基導入法
US20050176680A1 (en) 2003-12-11 2005-08-11 Sepracor, Inc. Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
CA2577060A1 (en) 2004-08-13 2006-02-23 Amgen Inc. Substituted benzofused heterocycles
WO2006040038A1 (en) * 2004-10-12 2006-04-20 F.Hoffmann-La Roche Ag Imidazo [1, 5-a]triazolo[1, 5-d]benzodiazepine derivatives for the treatment of cognitive disorders
ES2399439T3 (es) * 2004-10-20 2013-04-01 F. Hoffmann-La Roche Ag Derivados de imidazo-benzodiazepina
AU2005299031B2 (en) * 2004-10-20 2011-11-10 F. Hoffmann-La Roche Ag Halogen substituted benzodiazepine derivatives
BRPI0515800A (pt) 2004-12-14 2008-08-05 Hoffmann La Roche imidazo-benzodiazepinas tetracìclicas como moduladores de receptores de gaba
US8510055B2 (en) 2005-08-03 2013-08-13 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
EP1924712B1 (en) * 2005-08-03 2018-10-03 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
KR101009860B1 (ko) * 2005-10-11 2011-01-19 에프. 호프만-라 로슈 아게 이미다조 벤조다이아제핀 유도체
US20070112017A1 (en) * 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US9156836B2 (en) * 2008-05-16 2015-10-13 Synta Pharmaceuticals Corp. Tricyclic triazole compounds that modulate HSP90 activity
KR101385433B1 (ko) * 2008-11-18 2014-04-14 에프. 호프만-라 로슈 아게 다이하이드로테트라아자벤조아줄렌의 알킬사이클로헥실에터
HRP20131067T1 (hr) * 2008-11-28 2013-12-06 F. Hoffmann - La Roche Ag Arilcikloheksileteri od dihidrotetraazabenzoazulena za primjenu kao antagonista receptora vazopresina v1a
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
EP3034079B1 (en) 2010-11-15 2018-01-10 Agenebio, Inc. Pyridazine derivatives, compositions and methods for treating cognitive impairment
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
CA2885148A1 (en) * 2012-09-21 2014-03-27 Uwm Research Foundation, Inc. Novel gabaa agonists and methods of using to control airway hyperresponsiveness and inflammation in asthma
EP3083569B1 (en) * 2013-12-20 2022-01-26 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
JP6987384B2 (ja) * 2015-06-19 2021-12-22 エージンバイオ, インコーポレイテッド ベンゾジアゼピン誘導体、組成物、および認知障害を処置するための方法
US10059718B2 (en) * 2016-01-04 2018-08-28 Tabomedex Biosciences, LLC Fused quadracyclic compounds, compositions and uses thereof
US10973479B2 (en) 2016-05-16 2021-04-13 Canon Medical Systems Corporation X-ray diagnosis apparatus, X-ray diagnosis apparatus controlling method, and X-ray diagnosis system
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US20180170941A1 (en) * 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
KR102512548B1 (ko) 2017-12-22 2023-03-22 삼성디스플레이 주식회사 유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물
US11414425B2 (en) 2018-06-19 2022-08-16 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
KR102151969B1 (ko) * 2019-12-11 2020-09-04 주식회사 지투비 투과도 가변창의 제조방법 및 그에 의해 제조된 투과도 가변창
CN112979658B (zh) * 2021-02-22 2022-05-31 南湖实验室 一种氟马西尼的制备方法
WO2024039886A1 (en) 2022-08-19 2024-02-22 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK174086D0 (da) 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
TW201311B (https=) 1991-06-17 1993-03-01 Hoffmann La Roche

Also Published As

Publication number Publication date
MY141675A (en) 2010-06-15
ATE268776T1 (de) 2004-06-15
HUP0303281A3 (en) 2005-05-30
MA26962A1 (fr) 2004-12-20
DE60103776T2 (de) 2005-07-14
CN1191255C (zh) 2005-03-02
PT1337535E (pt) 2004-09-30
CA2427576C (en) 2007-11-06
BG107817A (bg) 2004-07-30
CN1474820A (zh) 2004-02-11
NO324706B1 (no) 2007-12-03
WO2002040487A3 (en) 2002-09-26
AR031345A1 (es) 2003-09-17
CA2427576A1 (en) 2002-05-23
EP1337535A2 (en) 2003-08-27
RU2278865C2 (ru) 2006-06-27
CZ20031597A3 (cs) 2003-11-12
DK1337535T3 (da) 2004-10-25
HRP20030360A2 (en) 2005-04-30
AU1700702A (en) 2002-05-27
DE60103776D1 (de) 2004-07-15
RU2003116895A (ru) 2005-02-20
AU2002217007B2 (en) 2006-11-30
KR100504300B1 (ko) 2005-07-28
ES2220831T3 (es) 2004-12-16
GC0000375A (en) 2007-03-31
JP4088151B2 (ja) 2008-05-21
IL155813A0 (en) 2003-12-23
HUP0303281A2 (hu) 2004-01-28
SI1337535T1 (en) 2004-10-31
ZA200303435B (en) 2004-08-05
UY27026A1 (es) 2002-06-20
YU35603A (sh) 2006-05-25
US20020103371A1 (en) 2002-08-01
JO2359B1 (en) 2006-12-12
SK7232003A3 (en) 2004-03-02
NZ525413A (en) 2005-02-25
TR200402073T4 (tr) 2004-10-21
EP1337535B1 (en) 2004-06-09
CZ295256B6 (cs) 2005-06-15
ECSP034607A (es) 2003-06-25
PE20020583A1 (es) 2002-07-06
NO20032208D0 (no) 2003-05-15
JP2004517070A (ja) 2004-06-10
NO20032208L (no) 2003-05-15
TWI239333B (en) 2005-09-11
BR0115393A (pt) 2004-07-06
MXPA03004251A (es) 2003-09-22
PL362925A1 (en) 2004-11-02
US6743789B2 (en) 2004-06-01
WO2002040487A2 (en) 2002-05-23
KR20030045192A (ko) 2003-06-09
HK1062442A1 (en) 2004-11-05
GT200100230A (es) 2002-07-04

Similar Documents

Publication Publication Date Title
PA8532401A1 (es) Derivados de imidazol [1,5-a][1,2,4]triazolo[4,3-d][1,4] benzodiazepina
CO5660266A2 (es) Sal de acido fosforico de un inhibidor de la dipeptidil peptidasa-iv
FI73430C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara tetracykliska t-butylimidazodiazepin-1-karboxylat.
RU2124015C1 (ru) Производные пирроло [2,3-d] пиримидинов, фармацевтическая композиция, пирроло [2,3-d] пиримидины, производные пиррола
ES2325596T3 (es) Derivados de pirrolopirimidina y pirrolopiridina sustituidos con un grupo amino ciclico.
WO2001019829A3 (en) Pyrazolopyrimidines as therapeutic agents
KR970707131A (ko) 티에노피리딘 또는 티에노피리미딘 유도체 및 그의 용도(thienopyridine or thienopyrimidine derivatives and their use)
GT200100137A (es) Pro-drogas de derivados de 4-fenil-piridina.
EA200200337A1 (ru) ПРОИЗВОДНЫЕ ПИРАЗОЛО[4,3-d]ПИРИМИДИНА
PT1121363E (pt) Pirazole[3,4-d]pirimidin-4-onas substituidas na posicao 6, uteis como inibidores de cinase dependentes de ciclina
CO5560547A2 (es) Metodos para la preparacion de compuestos de pirrolotriazina utiles como inhibidores de cinasa
PT588858E (pt) Derivados de imidazo¬2,1-b|benzazepina composicoes e metodo para a sua utilizacao
YU90003A (sh) Derivati imidazo/1,5-a/pirimido/5,4-d//1/benzazepina kao modulatori gaba a raceptora
ES2260300T3 (es) Compuestos tetraciclicos sustituidos con amino utiles como agentes antiinflamatorios y composiciones farmaceuticas que comprenden los mismos.
AU716633B2 (en) Amide derivatives
NO20055510L (no) 2-alkynyl- og 2-alkenylpyrazolo [4,3-E]-1,2,4-triazolo-[1,5-C]-pyrimidin-adenosin A2A-reseptorantagonister
MX2022009884A (es) Compuestos de 7-(metilamino)pirazolo[1,5-a]pirimidin-3-carboxamida .
CO5031239A1 (es) Derivados de triazolo-piridazina como ligandos para recepto- res de gaba
TW200630372A (en) Imidazo-benzodiazepine derivatives
BRPI0517412A (pt) derivados de benzodiazepina substituìdos
PA8534701A1 (es) DERIVADOS DE [1, 2, 4] TRIAZOLO [1,5-a] PIRIDINA
GT200100232A (es) Derivados de pirimidina.
BRPI0516244A (pt) derivados de benzodiazepina substituìda por halogênio
PA8558701A1 (es) Derivados de benzotiazol
GT200200044A (es) Compuestos farmaceuticamente activos